Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Patent
1992-08-06
1995-04-25
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
514680, A61K 3105
Patent
active
054099595
ABSTRACT:
A method of inhibiting thrombus formation in a mammalian subject. The method involves administering to the subject a therapeutically effective dose of a calix(n)arene compound derivatized, at its ring positions meta to the bridge attachments to the ring, with polar substituents having terminal sulfonate groups, including esters and amides which are cleavable in vivo.
REFERENCES:
patent: 4443477 (1984-04-01), Witte et al.
Akerfeldt, S., et al., "Aromatic Sulfonic Acids as Viral Inhibitors. Structure-Activity Study using Rhino, Adeno 3, Herpes Simplex, and Influenza Viruses," J. Med. Chem. 14(7):596-600 (1971).
Manabe, O., and Shinkai, S., "Calixarene derivatives," abstract from Chem. Abst. 105:568 (1986).
Poh, B.-L., et al., "Complexations of Metal Cations with Cyclotetrachromotropylene in Water and Methanol," Tetrahedron 46(12):4379-4386 (1990).
Poh, B.-L., and Lim, C. S., "Complexations of Amines with Water-Soluble Cyclotetrachromotropylene," Tetrahedron 46(10):3651-3658 (1990).
Poh, B.-L., et al., "A Water-Soluble Cyclic Tetramer from Reacting Chromotropic Acid with Formaldehyde," Tetra. Letters 30(8):1005-1008 (1989).
Shinkai, S., et al., "Selective adsorption of uranyl ion (UO.sub.2.sup.2+) to a polymer resin immobilizing calixarene-based uranophiles," absract from Chem. Abst. 109:35 (1988).
Shinkai, S., et al., "Synthesis and inclusion properties of neutral water-soluble calixarene," abstract from Chem. Abst. 113:666 (1990).
Shinkai, S., et al., "New Syntheses of Calixarene-p-sulfonates and p-Nitrocalixarenes," J. Chem. Soc. Perkin Trans. I:2297-2299 (1987).
Shinkai, S., et al., "Hexasulfonated Calix[6]arene Derivatives: A New Class of Catalysts, Surfactants, and Host Molecules," J. Am. Chem. Soc. 108:2409-2416 (1986).
Shinkai, S., et al., "New Water-Soluble Host Molecules Derived From Calix[6]arene," Tetra. Letters 25(46):5315-5318 (1984).
Kawasaki, M., "Spot prevention in silver halide photographic material," Chemical Abstracts 117(16): abstract no. 160793y (1992).
Chen Jen
Choy William
Hwang Kou M.
Lee Thomas C.
Liu Su-Ying
Dehlinger Peter J.
Genelabs Incorporated
Henley III Raymond
Powers Vincent M.
Stratford Carol A.
LandOfFree
Antithrombotic treatment with calix(n)arene compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antithrombotic treatment with calix(n)arene compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antithrombotic treatment with calix(n)arene compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1568201